Regal Funds Reduces Stake in CardieX Ltd

TipRanksApr 22 02:57 ET

Australian Shares Inch Down As Market Assesses RBA Policy Meeting Minutes

Australian shares retreated slightly on Tuesday as the market assessed the minutes of the central bank's March policy meeting. The S&P/ASX 200 Index slid 9.00 points, or 0.1%, to 7,887.90. Minutes of

MT NewswiresApr 2 01:54 ET

Cardiex Marks Two Milestones Toward Wearable Biomarker Technology Commercialization; Shares Up 5%

Health technology company Cardiex (ASX:CDX) completed its HEARTsense study and secured another patent for its CONNEQT Band wearable technology, marking two milestones in the commercialization of its w

MT NewswiresApr 1 22:04 ET

CARDIEX Secures Higher Credit Facility From C2 Ventures

CARDIEX (ASX:CDX) provided an update regarding its funding commitment agreement (FCA) with C2 Ventures, saying the facility limit has been increased by AU$966,434.40, boosting it to roughly AU$8.5 mil

MT NewswiresMar 15 08:03 ET

CardieX Advances Trade Reinstatement Process With Australian Bourse

CardieX (ASX:CDX) advanced the process to lift its trading suspension in place since Sept. 8, 2023, following a recent AU$4 million placement and a AU$4 million entitlement offer, according to a Tuesd

MT NewswiresJan 1 23:13 ET

CardieX Sets U.S. IPO at 1.33 Million ADSs Priced at $7.50-$8 Each

Australian medical-device maker CardieX on Wednesday said it plans to sell more than 1.33 million American depositary shares at between $7.50 and $8 apiece in its U.S. initial public offering.

Dow JonesAug 30, 2023 06:54 ET